Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial

BACKGROUND: Prostate cancer is the most common cancer in males in the UK and affects around 105 men for every 100,000. The role of radiotherapy in the management of prostate cancer significantly changed over the last few decades with developments in brachytherapy, external beam radiotherapy (EBRT),...

Descripción completa

Detalles Bibliográficos
Autores principales: Palvai, Sreekanth, Harrison, Michael, Shibu Thomas, Sharon, Hayden, Karen, Green, James, Anderson, Oliver, Romero, Lavinia, Lodge, Richard, Burns, Patricia, Ahmed, Imtiaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications Inc. 2015
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430680/
https://www.ncbi.nlm.nih.gov/pubmed/25926023
http://dx.doi.org/10.2196/resprot.4462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430680/
https://www.ncbi.nlm.nih.gov/pubmed/25926023
http://dx.doi.org/10.2196/resprot.4462

Ejemplares similares